drug · small molecule
cysteamine
Phase 2updated 3mo agoby Novabiotics Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 3 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying cysteamine
- phase2PK and PD Study of NPI-001 and Cysteamine Bitartrate
- phase2A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)
- phase2A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
- phase2Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
- phase3Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)
- phase3Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that